- Home
- Automated
- List of product information
- ALERCHEK OPHTHALMIC SOLUTION 0.1% [SIN15527P]
ALERCHEK OPHTHALMIC SOLUTION 0.1% [SIN15527P]
Active ingredients: ALERCHEK OPHTHALMIC SOLUTION 0.1%
Product Info
ALERCHEK OPHTHALMIC SOLUTION 0.1%
[SIN15527P]
Product information
Active Ingredient and Strength | OLOPATADINE HYDROCHLORIDE 1.11 MG/ML EQV OLOPATADINE - 1 MG/ML |
Dosage Form | SOLUTION, STERILE |
Manufacturer and Country | INDOCO REMEDIES LIMITED - INDIA |
Registration Number | SIN15527P |
Licence Holder | GOLDPLUS UNIVERSAL PTE LTD |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | S01GX09 |
INDICATIONS
ALERCHEK 0.1% (olopatadine hydrochloride ophthalmic solution 0.1%) is indicated for the treatment of the signs and symptoms of allergic conjunctivitis.
DOSAGE AND ADMINISTRATION
Dosage
The recommended dose is 1 drop in each affected eye 2 times per day.
Use in children
Safety and effectiveness in paediatric patients below the age of 3 years have not been established.
Use in patients with hepatic or renal impairment
No clinical studies with ALERCHEK 0.1% eye drops have been conducted in patients with renal or hepatic impairment; therefore the efficacy and safety of ALERCHEK 0.1% eye drops in these patients have yet to be established.
Method of administration
For ocular use.
After cap is removed, if tamper evident snap collar is loose, remove before using product.
To prevent contamination of the dropper tip and solution, care must be taken not to touch the eyelids, surrounding areas or other surfaces with the dropper tip. Keep the bottle tightly closed when not in use.
Nasolacrimal occlusion or gently closing the eyelid after administration is recommended. This may reduce the systemic absorption of medicinal products administered via the ocular route and result in a decrease in systemic adverse reactions.
If more than one topical ophthalmic product is being used, the products must be administered at least 5 minutes apart. Eye ointments should be administered last.
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients.
